Pancreatic Cancer Research

ResearcherCapital Medical UniversityActive in the last 2 years

Xiukun Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-0306-4953; OpenAlex author ID A5074822731. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 7)
Trials
0
Grants
0
Labs led
2
Collaborators
10
Papers, trials and grants by year

2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 7

  1. Interaction between Maslinic acid and HSF1 enhances the ubiquitin degradation of HSF1, resulting in the inhibitory effect of pancreatic cancer. Last author DOI 10.1007/s12672-025-02786-8↗
  2. Chlorogenic Acid Inhibits Proliferation, Migration and Invasion of Pancreatic Cancer Cells via AKT/GSK-3β/β-catenin Signaling Pathway. Last author DOI 10.2174/1574892818666230327134746↗
  3. Exosomes-Coated miR-34a Displays Potent Antitumor Activity in Pancreatic Cancer Both in vitro and in vivo. Last author DOI 10.2147/dddt.s265423↗
  4. Zinc-Doped Copper Oxide Nanocomposites Inhibit the Growth of Pancreatic Cancer by Inducing Autophagy Through AMPK/mTOR Pathway. Last author DOI 10.3389/fphar.2019.00319↗
  5. Maslinic acid induces autophagy by down-regulating HSPA8 in pancreatic cancer cells. Last author DOI 10.1002/ptr.6064↗
  6. Oleanolic acid arrests cell cycle and induces apoptosis via ROS-mediated mitochondrial depolarization and lysosomal membrane permeabilization in human pancreat… Last author DOI 10.1002/jat.2725↗
  7. Oleanolic acid potentiates the antitumor activity of 5-fluorouracil in pancreatic cancer cells. Last author DOI 10.3892/or.2012.1921↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ammad Ahmad Farooqı · 3 shared papers, 2018–2025 · strength 0.44
  2. Xiaoliang Chen · 2 shared papers, 2018–2024 · strength 0.31
  3. Huanli Xu · 3 shared papers, 2018–2020 · strength 0.29
  4. Li Cheng · 1 shared paper, 2025 · strength 0.27
  5. Linlin Wang · 1 shared paper, 2025 · strength 0.27
  6. Ling Zuo · 1 shared paper, 2020 · strength 0.11
  7. Xiao Li · 1 shared paper, 2019 · strength 0.10
  8. Ye Tian · 1 shared paper, 2018 · strength 0.07
  9. Jianteng Wei · 2 shared papers, 2012–2013 · strength 0.07
  10. Ning Wu · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.